![David M. Hilbert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David M. Hilbert
Plus aucun poste en cours
Profil
David M.
Hilbert was the founder of Arcellx, Inc. (founded in 2014), where he held the titles of President, Chief Executive Officer & Director until 2021.
He was also a former Director & Chief Scientific Officer at Zyngenia, Inc. in 2012, Vice President-Research at Human Genome Sciences, Inc., and Vice President-Research at Cellective Therapeutics, Inc. from 2004 to 2008.
Additionally, he worked as a Principal at the National Cancer Institute.
Dr. Hilbert holds a doctorate from the University of Pennsylvania and an undergraduate degree from Haverford College.
Anciens postes connus de David M. Hilbert
| Sociétés | Poste | Fin |
|---|---|---|
Cellective Therapeutics, Inc.
 Cellective Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Provides biopharmaceutical products | Corporate Officer/Principal | 14/11/2008 |
| ARCELLX, INC. | Directeur Général | 22/01/2021 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Corporate Officer/Principal | - |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Directeur Technique/Scientifique/R&D | - |
Formation de David M. Hilbert
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Retail Trade |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Haverford College
 Haverford College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellective Therapeutics, Inc.
Cellective Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Provides biopharmaceutical products | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Arcellx, Inc.
 Arcellx, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies | Health Technology |
